XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect of Accounting Change
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Retained earnings
Retained earnings
Cumulative Effect of Accounting Change
Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2019 $ 532,386   $ 340,397     $ 180,265   $ 11,724
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ 822         $ 822  
Beginning balance (in shares) at Dec. 31, 2019       37,401,443 2,915,531      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (3,825)         (3,825)    
Other comprehensive income (loss) 13,579             13,579
Issuance of restricted stock (in shares)       29,389        
Tax withholding related to vesting of restricted stock and other (109)   (109)          
Employee stock purchase program 232   232          
Employee stock purchase program (Shares)       25,161        
Stock option exercises 406   406          
Stock option exercises (in shares)       64,181        
Stock option based compensation expense 772   772          
Restricted stock expense 5,475   5,475          
Issuance of common stock in connection with acquisition of wholly-owned subsidiary 1,122   1,122          
Issuance of common stock in connection with acquisition of wholly-owned subsidiary (in shares)       89,927        
Non-voting common stock converted to voting common stock in private sale (Shares)       200,000 (200,000)      
Cash dividends (2,425)         (2,425)    
Ending balance at Jun. 30, 2020 548,435   348,295     174,837   25,303
Ending balance (in shares) at Jun. 30, 2020       37,810,101 2,715,531      
Beginning balance at Mar. 31, 2020 533,772   343,747     172,276   17,749
Beginning balance (in shares) at Mar. 31, 2020       37,664,670 2,715,531      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 3,777         3,777    
Other comprehensive income (loss) 7,554             7,554
Issuance of restricted stock (in shares)       21,965        
Tax withholding related to vesting of restricted stock and other (61)   (61)          
Stock option exercises 148   148          
Stock option exercises (in shares)       33,539        
Stock option based compensation expense 406   406          
Restricted stock expense 2,933   2,933          
Issuance of common stock in connection with acquisition of wholly-owned subsidiary 1,122   1,122          
Issuance of common stock in connection with acquisition of wholly-owned subsidiary (in shares)       89,927        
Cash dividends (1,216)         (1,216)    
Ending balance at Jun. 30, 2020 548,435   348,295     174,837   25,303
Ending balance (in shares) at Jun. 30, 2020       37,810,101 2,715,531      
Beginning balance at Dec. 31, 2020 567,850   310,619     235,724   21,507
Beginning balance (in shares) at Dec. 31, 2020       41,344,689 1,107,757      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 103,009         103,009    
Other comprehensive income (loss) (8,384)             (8,384)
Issuance of restricted stock (in shares)       416,823        
Tax withholding related to vesting of restricted stock and other (17,000)   (17,000)          
Employee stock purchase program 296   296          
Employee stock purchase program (Shares)       5,686        
Stock option exercises 2,164   2,164          
Stock option exercises (in shares)       389,505        
Stock option based compensation expense 697   697          
Restricted stock expense 8,437   8,437          
Non-voting common stock converted to voting common stock in private sale (Shares)       597,430 (597,430)      
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 2,857         2,857    
Cash dividends (2,579)         (2,579)    
Ending balance at Jun. 30, 2021 657,347   305,213     339,011   13,123
Ending balance (in shares) at Jun. 30, 2021       42,754,133 510,327      
Beginning balance at Mar. 31, 2021 590,360   305,855     275,377   9,128
Beginning balance (in shares) at Mar. 31, 2021       42,259,091 692,253      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 63,582         63,582    
Other comprehensive income (loss) 3,995             3,995
Issuance of restricted stock (in shares)       124,607        
Tax withholding related to vesting of restricted stock and other (5,713)   (5,713)          
Stock option exercises 951   951          
Stock option exercises (in shares)       188,509        
Stock option based compensation expense 353   353          
Restricted stock expense 3,767   3,767          
Non-voting common stock converted to voting common stock in private sale (Shares)       181,926 (181,926)      
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 1,349         1,349    
Cash dividends (1,297)         (1,297)    
Ending balance at Jun. 30, 2021 $ 657,347   $ 305,213     $ 339,011   $ 13,123
Ending balance (in shares) at Jun. 30, 2021       42,754,133 510,327